Plasminogen activator inhibitor-1 gene-deficient mice: II. effects on hemostasis, thrombosis, and thrombolysis

Journal of Clinical Investigation

Volumn 92, Issue 6, 1993, Pages 2756-2760

  Carmeliet, Peter ^a,b   Stassen, Jean Marie ^a   Schoonjans, Luc ^a   Ream, Beverly ^b   Van Den Oord, Joost J ^c   De Mol, Maria ^a   Mulligan, Richard C ^b   Collen, Désiré ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Embryonic stem cells; Fibrinolysis; Gene targeting; Homologous recombination

Indexed keywords

ENDOTOXIN; FIBRIN; FIBRINOGEN; IODINE 125; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLEEDING TENDENCY; BLOOD CLOT LYSIS; FIBRINOLYSIS; GENE DISRUPTION; HEMOSTASIS; LEUKOCYTE DIFFERENTIAL COUNT; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOGENESIS; THROMBOSIS;

ANALYSIS OF VARIANCE; ANIMAL; CECUM; ENDOTOXINS; ERYTHROCYTE COUNT; FIBRIN; FIBRINOLYSIS; HEMATOCRIT; HEMOGLOBINS; HEMORRHAGE; HEMOSTASIS; MICE; MICE, INBRED STRAINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET COUNT; PULMONARY EMBOLISM; THROMBOSIS;

EID: 0027135792     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116893     Document Type: Article

References (32)

1. Astrup, T. 1991. Fibrinolysis: Past and present, a reflection of fifty years. Semin. Thromb. Hemostasis 17:161-174.
2. Collen, D., and H. R. Lijnen. 1991. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 78:3114-3124.
3. Schneiderman, J., and D. J. Loskutoff. 1991. Plasminogen activator inhibitors. Trends Cardiovasc. Med. 1:99-102.
4. Diéval, J., G. Nguyen, S. Gross, J. Delobel, and E. K. O. Kruithof, 1991. A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood. 77:528-532.
5. Lee, M. H., E. Vosburgh, K. Anderson, and J. McDonagh. 1993. Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding. Blood. 81:2357-2362.
6. Schleef, R. R., D. L. Higgins, E. Pillemer, and L. J. Levitt. 1989. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J. Clin. Invest. 83:1747-1752.
7. Francis, R. B., Jr., H. Liebman, S. Koehler, and D. I. Feinstein. 1986. Accelerated fibrinolysis in amyloidosis: specific binding of tissue plasminogen activator inhibitor by an amyloidogenic monoclonal IgG. Blood. 68 (Suppl. 1):333. (Abstr.)
8. Fay, W. P., A. D. Shapiro, J. L. Shih, R. R. Schleef, and D. Ginsburg. 1992. Complete deficiency of plasminogen-activator inhibitor type 1 due to a frameshift mutation. N. Engl. J. Med. 327:1729-1733.
9. Nilsson, I. M., H. Ljungner, and L. Tengborn. 1985. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br. Med. J. 290:1453-1455.
10. Colucci, M., J. A. Paramo, and D. Collen. 1985. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J. Clin. Invest. 75:818-824.
11. Aillaud, M. F., I. Juhan-Vague, M. C. Alessi, M. Marecal, M. F. Vinson, C. Arnoud, P. H. Vague, and D. Collen. 1985. Increased PA-inhibitor levels in the postoperative period. No cause-effect relation with increased cortisol. Thromb Haemost 54:466-468.
12. Sprengers, E. D., and C. Kluft. 1987. Plasminogen activator inhibitors. Blood. 69:381-387.
13. Paramo, J. A., M. Colucci, and D. Collen. 1985. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br. Med. J. 291:573-574.
14. Aznar, J., A. Estelles, G. Tormo, P. Sapena, V. Tormo, S. Blanch, and F. Espana. 1988. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Br Heart J. 58:535-541.
15. Hamsten, A., U. de Faire, G. Walldius, G. Dahlen, A. Szamosi, C. Landou, M. Blombäck, and B. Wiman. 1987. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. ii:3-9.
16. Erickson, L. A., G. J. Fici, J. E. Lund, T. P. Boyle, H. G. Polites, and K. R. Marotti. 1990. Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature (Lond.). 346:74-76.
17. Levi, M., B. J. Biemond, A.-J. van Zonneveld, J. W. ten Cate, and H. Pannekoek. 1992. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 85:305-312.
18. Juhan-Vague, I., and D. Collen. 1992. On the role of coagulation and fibrinolysis in atherosclerosis. Ann. Epidemiol. 2:427-438.
19. Juhan-Vague, I., M. C. Alessi, and P. Vague. 1991. Increased plasma plasminogen activator inhibitor-1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia. 34:457-462.
20. Schneiderman, J., M. S. Sawdey, M. R. Keeton, G. M. Bordin, E. F. Bernstein, R. B. Dilley, and D. J. Loskutoff. 1992. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA. 89:6998-7002.
21. Lupu, R, G. E. Bergonzelli, D. A. Heim, E. Cousin, C. Y. Genton, F. Bachmann, and E. K. O. Kruithof. 1993. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arteriosder. Thromb. 13:1090-1100.
22. Juhan-Vague, I., M. F. Aillaud, F. De Cock, C. Philip-Joet, C. Arnaud, A. Serradimigni, and D. Collen. 1985. The fast-acting inhibitor of tissue-type plasminogen activator is an acute phase protein. Progr. Fibrinol. 7:146-149.
23. Carmeliet, P., L. Kieckens, L. Schoonjans, B. Ream, A. Van Nuffelen, G. Prendergast, M. Cole, R. Bronson, D. Collen, and R. C. Mulligan. Plasminogen activator inhibitor-1 gene deficient mice. I. Generation by homologous recombination and characterization. J. Clin. Invest. 92:2746-2755.
24. Gallimore, M. J., H. M. Tyler, and J. T. Shaw, J. T. 1971. The measurement of fibrinolysis in rat. Thromb. Diath. Haemorrh. 26:295-310.
25. Vermylen, C., R. De Vreker, and M. Verstraete. 1963. Rapid enzymatic method for assay of fibrinogen-fibrin polymerization time (FPT-test). Clin. Chim. Acta. 8:418-424.
26. Stassen, J. M., I. Vanlinthout, H. R. Lijnen, and D. Collen. 1990. A hamster pulmonary embolism model for the evaluation of the thrombolytic and pharmacokinetic properties of thrombolytic agents. Fibrinolysis. 4:15-21.
27. Heremans, H., R. Dijkmans, H. Sobis, F. Vandekerckhove, and A. Billiau. 1987. Regulation by interferons of the local inflammatory response to bacterial liposaccharide. J. Immunol 138:4175-4179.
28. Keeton, M., Y. Eguchi, M. Sawdey, C. Ahn, and D. J. Loskutoff. 1993. Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am. J. Pathol. 142:59-70.
29. Sawdey, M. S., and D. J. Loskutoff. 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J. Clin. Invest. 88:1346-1353.
30. Quax, P. H. A., C. M. van den Hoogen, J. H. Verheijen, T. Padro, R. Zeheb, T. D. Gelehrter, T. J. C. van Berkel, J. Kuiper, and J. J. Emeis. 1990. Endotoxin induction of plasminogen activator and plasminogen activator inhibi-tor type 1 mRNA in rat tissues in vivo. J. Biol. Chem. 265:15560-15563.
31. Tomooka, S., W. A. Border, B. C. Marshall, and N. A. Noble. 1992. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int. 42:1462-1469.
32. Blasi, F., and P. Verde. 1990. Urokinase-dependent cell surface proteolysis and cancer. Semin. Cancer Biol. 1:117-126.